XML 64 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Investments in Marketable Securities
6 Months Ended
Jun. 30, 2014
Investments, Debt and Equity Securities [Abstract]  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note 8 Investments in Marketable Securities


Our investments in marketable securities are classified as available for sale securities. Realized gains and losses from securities sales are recognized in results of operations upon disposition of the securities using the specific identification method on a trade date basis. Refer to Note 9 for a description of the Company's methodology for determining the fair value of marketable securities.


Marketable securities and restricted marketable securities consist of the following:


   

June 30, 2014

   

December 31, 2013

 

(in thousands)

 

Amortized

Cost

   

Fair

Value

   

Amortized

Cost

   

Fair

Value

 

Investments available for sale:

                               

Marketable equity securities

  $ 30,176     $ 117,618     $ 30,176     $ 105,009  

Restricted investments available for sale:

                         

Corporate debt securities

    66,364       66,761       65,852       65,006  

Commercial mortgage–backed securities

    54,404       54,267       46,977       45,856  

U.S. Treasury securities

    13,880       13,905       22,932       22,841  

State and municipal securities

    11,941       12,285       8,123       8,300  
    $ 176,765     $ 264,836     $ 174,060     $ 247,012  

Included in the available for sale marketable equity securities are the following (in thousands, except share amounts):


   

June 30, 2014

   

December 31, 2013

 
   

Shares

   

Cost

   

 

Fair

Value

   

Shares

   

Cost

   

Fair

Value

 

NHI Common Stock

    1,630,642     $ 24,734     $ 102,013       1,630,642     $ 24,734     $ 91,479  

The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows:


   

June 30, 2014

   

December 31, 2013

 

(in thousands)

 

Cost

   

Fair

Value

   

Cost

   

Fair

Value

 

Maturities:

                               

Within 1 year

  $ 11,789     $ 11,849     $ 9,279     $ 9,324  

1 to 5 years

    86,787       87,807       91,787       92,011  

6 to 10 years

    47,045       46,724       40,387       38,335  

Over 10 years

    968       838       2,431       2,333  
    $ 146,589     $ 147,218     $ 143,884     $ 142,003  

Gross unrealized gains related to available for sale securities are $89,049,000 and $75,702,000 as of June 30, 2014 and December 31, 2013, respectively. Gross unrealized losses related to available for sale securities are $978,000 and $2,750,000 as of June 30, 2014 and December 31, 2013, respectively. For the marketable securities in gross unrealized loss positions, (a) it is more likely than not that the Company will not be required to sell the investment securities before recovery of the unrealized losses, and (b) the Company expects that the contractual principal and interest will be received on the investment securities. As a result, the Company recognized no other-than-temporary impairment during the six months ended June 30, 2014 or the year ended December 31, 2013.


Proceeds from the sale of investments in restricted marketable securities during the six months ended June 30, 2014 and 2013 were $27,641,000 and $38,150,000, respectively. Investment gains of $172,000 and $384,000 were realized on these sales during the six months ended June 30, 2014 and 2013, respectively.